Jane Street
APLS

Jane Street’s Apellis Pharmaceuticals APLS Stock Holding History

Jane Street’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.5M Sell
161,500
-111,000
-41% -$2.39M ﹤0.01% 3122
2025
Q4 		$6.85M Buy
272,500
+64,000
+31% +$1.5M ﹤0.01% 2790
2025
Q3 		$4.72M Sell
208,500
-7,100
-3% -$166K ﹤0.01% 3505
2025
Q2 		$3.73M Sell
215,600
-113,500
-34% -$2.1M ﹤0.01% 3416
2025
Q1 		$7.2M Buy
329,100
+24,100
+8% +$666K ﹤0.01% 2407
2024
Q4 		$9.73M Buy
305,000
+31,600
+12% +$950K ﹤0.01% 1911
2024
Q3 		$7.88M Sell
273,400
-93,200
-25% -$3.45M ﹤0.01% 2188
2024
Q2 		$14.1M Buy
366,600
+253,100
+223% +$11.5M ﹤0.01% 1655
2024
Q1 		$6.67M Sell
113,500
-102,300
-47% -$6.52M ﹤0.01% 2245
2023
Q4 		$12.9M Sell
215,800
-70,700
-25% -$3.59M ﹤0.01% 1680
2023
Q3 		$10.9M Buy
286,500
+125,900
+78% +$5.53M ﹤0.01% 1686
2023
Q2 		$14.6M Buy
160,600
+11,500
+8% +$992K ﹤0.01% 1513
2023
Q1 		$9.83M Buy
149,100
+88,600
+146% +$5.11M ﹤0.01% 1653
2022
Q4 		$3.13M Sell
60,500
-60,200
-50% -$3.19M ﹤0.01% 3154
2022
Q3 		$8.24M Sell
120,700
-9,300
-7% -$550K ﹤0.01% 1910
2022
Q2 		$5.88M Sell
130,000
-12,600
-9% -$574K ﹤0.01% 2432
2022
Q1 		$7.25M Buy
142,600
+106,300
+293% +$4.69M ﹤0.01% 2450
2021
Q4 		$1.72M Sell
36,300
-798,000
-96% -$31.4M ﹤0.01% 4792
2021
Q3 		$27.5M Buy
834,300
+772,000
+1,239% +$43.4M 0.01% 919
2021
Q2 		$3.94M Buy
+62,300
New +$3.21M ﹤0.01% 3063
2021
Q1 		– Sell
-11,700
Closed -$669K – 9046
2020
Q4 		$669K Sell
11,700
-12,100
-51% -$512K ﹤0.01% 5304
2020
Q3 		$718K Buy
23,800
+6,500
+38% +$194K ﹤0.01% 4619
2020
Q2 		$565K Buy
+17,300
New +$556K ﹤0.01% 4890

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jane Street's APLS Position: Q1 2026 in Review

Jane Street sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 50,114 shares — an estimated $1.08M sold.

Jane Street first reported a position in APLS in Q2 2019 and held it in 26 quarters. The position peaked at $43.8M in Q2 2023. 321 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Jane Street reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 50,114 Apellis Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
  • Jane Street first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 26 quarters.
  • Jane Street's Apellis Pharmaceuticals position peaked at $43.8M in Q2 2023.
  • 321 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.